Brain serotonin synthesis capacity in obsessive-compulsive disorder: Effects of cognitive behavioral therapy and sertraline

Jennifer I. Lissemore, Debbie Sookman, Paul Gravel, Alexandre Berney, Amir Barsoum, Mirko Diksic, Thomas E Nordahl, Gilbert Pinard, Igor Sibon, Jean Cottraux, Marco Leyton, Chawki Benkelfat

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are both effective treatments for some patients with obsessive-compulsive disorder (OCD), yet little is known about the neurochemical changes related to these treatment modalities. Here, we used positron emission tomography and the α-[11C]methyl-l-tryptophan tracer to examine the changes in brain regional serotonin synthesis capacity in OCD patients following treatment with CBT or SSRI treatment. Sixteen medication-free OCD patients were randomly assigned to 12 weeks of either CBT or sertraline treatment. Pre-to-post treatment changes in the α-[11C]methyl-l-tryptophan brain trapping constant, K∗(ml/g/min), were assessed as a function of symptom response, and correlations with symptom improvement were examined. Responders/partial responders to treatment did not show significant changes in relative regional tracer uptake; rather, in responders/partial responders, 12 weeks of treatment led to serotonin synthesis capacity increases that were brain-wide. Irrespective of treatment modality, baseline serotonin synthesis capacity in the raphe nuclei correlated positively with clinical improvement. These observations suggest that, for some patients, successful remediation of OCD symptoms might be associated with greater serotonergic tone.

Original languageEnglish (US)
Article number82
JournalTranslational Psychiatry
Volume8
Issue number1
DOIs
StatePublished - Dec 1 2018

Fingerprint

Sertraline
Obsessive-Compulsive Disorder
Cognitive Therapy
Serotonin
Brain
Therapeutics
Serotonin Uptake Inhibitors
Raphe Nuclei
Positron-Emission Tomography

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Biological Psychiatry

Cite this

Brain serotonin synthesis capacity in obsessive-compulsive disorder : Effects of cognitive behavioral therapy and sertraline. / Lissemore, Jennifer I.; Sookman, Debbie; Gravel, Paul; Berney, Alexandre; Barsoum, Amir; Diksic, Mirko; Nordahl, Thomas E; Pinard, Gilbert; Sibon, Igor; Cottraux, Jean; Leyton, Marco; Benkelfat, Chawki.

In: Translational Psychiatry, Vol. 8, No. 1, 82, 01.12.2018.

Research output: Contribution to journalArticle

Lissemore, JI, Sookman, D, Gravel, P, Berney, A, Barsoum, A, Diksic, M, Nordahl, TE, Pinard, G, Sibon, I, Cottraux, J, Leyton, M & Benkelfat, C 2018, 'Brain serotonin synthesis capacity in obsessive-compulsive disorder: Effects of cognitive behavioral therapy and sertraline', Translational Psychiatry, vol. 8, no. 1, 82. https://doi.org/10.1038/s41398-018-0128-4
Lissemore, Jennifer I. ; Sookman, Debbie ; Gravel, Paul ; Berney, Alexandre ; Barsoum, Amir ; Diksic, Mirko ; Nordahl, Thomas E ; Pinard, Gilbert ; Sibon, Igor ; Cottraux, Jean ; Leyton, Marco ; Benkelfat, Chawki. / Brain serotonin synthesis capacity in obsessive-compulsive disorder : Effects of cognitive behavioral therapy and sertraline. In: Translational Psychiatry. 2018 ; Vol. 8, No. 1.
@article{98a2324c3d5b4190a56c2361a4fb0bca,
title = "Brain serotonin synthesis capacity in obsessive-compulsive disorder: Effects of cognitive behavioral therapy and sertraline",
abstract = "Cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are both effective treatments for some patients with obsessive-compulsive disorder (OCD), yet little is known about the neurochemical changes related to these treatment modalities. Here, we used positron emission tomography and the α-[11C]methyl-l-tryptophan tracer to examine the changes in brain regional serotonin synthesis capacity in OCD patients following treatment with CBT or SSRI treatment. Sixteen medication-free OCD patients were randomly assigned to 12 weeks of either CBT or sertraline treatment. Pre-to-post treatment changes in the α-[11C]methyl-l-tryptophan brain trapping constant, K∗(ml/g/min), were assessed as a function of symptom response, and correlations with symptom improvement were examined. Responders/partial responders to treatment did not show significant changes in relative regional tracer uptake; rather, in responders/partial responders, 12 weeks of treatment led to serotonin synthesis capacity increases that were brain-wide. Irrespective of treatment modality, baseline serotonin synthesis capacity in the raphe nuclei correlated positively with clinical improvement. These observations suggest that, for some patients, successful remediation of OCD symptoms might be associated with greater serotonergic tone.",
author = "Lissemore, {Jennifer I.} and Debbie Sookman and Paul Gravel and Alexandre Berney and Amir Barsoum and Mirko Diksic and Nordahl, {Thomas E} and Gilbert Pinard and Igor Sibon and Jean Cottraux and Marco Leyton and Chawki Benkelfat",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41398-018-0128-4",
language = "English (US)",
volume = "8",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Brain serotonin synthesis capacity in obsessive-compulsive disorder

T2 - Effects of cognitive behavioral therapy and sertraline

AU - Lissemore, Jennifer I.

AU - Sookman, Debbie

AU - Gravel, Paul

AU - Berney, Alexandre

AU - Barsoum, Amir

AU - Diksic, Mirko

AU - Nordahl, Thomas E

AU - Pinard, Gilbert

AU - Sibon, Igor

AU - Cottraux, Jean

AU - Leyton, Marco

AU - Benkelfat, Chawki

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are both effective treatments for some patients with obsessive-compulsive disorder (OCD), yet little is known about the neurochemical changes related to these treatment modalities. Here, we used positron emission tomography and the α-[11C]methyl-l-tryptophan tracer to examine the changes in brain regional serotonin synthesis capacity in OCD patients following treatment with CBT or SSRI treatment. Sixteen medication-free OCD patients were randomly assigned to 12 weeks of either CBT or sertraline treatment. Pre-to-post treatment changes in the α-[11C]methyl-l-tryptophan brain trapping constant, K∗(ml/g/min), were assessed as a function of symptom response, and correlations with symptom improvement were examined. Responders/partial responders to treatment did not show significant changes in relative regional tracer uptake; rather, in responders/partial responders, 12 weeks of treatment led to serotonin synthesis capacity increases that were brain-wide. Irrespective of treatment modality, baseline serotonin synthesis capacity in the raphe nuclei correlated positively with clinical improvement. These observations suggest that, for some patients, successful remediation of OCD symptoms might be associated with greater serotonergic tone.

AB - Cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are both effective treatments for some patients with obsessive-compulsive disorder (OCD), yet little is known about the neurochemical changes related to these treatment modalities. Here, we used positron emission tomography and the α-[11C]methyl-l-tryptophan tracer to examine the changes in brain regional serotonin synthesis capacity in OCD patients following treatment with CBT or SSRI treatment. Sixteen medication-free OCD patients were randomly assigned to 12 weeks of either CBT or sertraline treatment. Pre-to-post treatment changes in the α-[11C]methyl-l-tryptophan brain trapping constant, K∗(ml/g/min), were assessed as a function of symptom response, and correlations with symptom improvement were examined. Responders/partial responders to treatment did not show significant changes in relative regional tracer uptake; rather, in responders/partial responders, 12 weeks of treatment led to serotonin synthesis capacity increases that were brain-wide. Irrespective of treatment modality, baseline serotonin synthesis capacity in the raphe nuclei correlated positively with clinical improvement. These observations suggest that, for some patients, successful remediation of OCD symptoms might be associated with greater serotonergic tone.

UR - http://www.scopus.com/inward/record.url?scp=85045614299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045614299&partnerID=8YFLogxK

U2 - 10.1038/s41398-018-0128-4

DO - 10.1038/s41398-018-0128-4

M3 - Article

C2 - 29666372

AN - SCOPUS:85045614299

VL - 8

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

IS - 1

M1 - 82

ER -